Testing effectiveness (Phase 2)Study completedNCT04007107
What this trial is testing
A Study Comparing the Injection Site Pain Experience After the Injection of 2 Different Solutions of Semaglutide With 2 Different Injection Pens, a Compound for the Treatment of Type 2 Diabetes and Obesity
Who this might be right for
Healthy Volunteers Diabetes Mellitus, Type 2Healthy Volunteers OverweightHealthy Volunteers Obesity
Novo Nordisk A/S 103